Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

CD7-Positive Hematological Malignancies × Automobiles × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Non-Hodgkin 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 CD7-Positive Hematological Malignancies 1 Burkitt Lymphoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07345780 2026-01-16

Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies

Tongji Hospital

Phase NA Not yet recruiting

CD7-Positive Hematological Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡